Turmeric for Patients With Basal Joint Arthritis
A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis
Massachusetts General Hospital
60 participants
Aug 9, 2017
INTERVENTIONAL
Conditions
Summary
The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.
Eligibility
Inclusion Criteria6
- years of age or older
- English fluency and literacy
- Seeking care for basal joint pain
- Tender over basal joint
- Positive distraction rotation test (rotation of the thumb metacarpal base while applying axial traction)
- Radiographic evidence of Eaton stage 1 and 2 only
Exclusion Criteria9
- Secondary gains (litigations or worker compensation) procedures that may interfere with patients' motivation for treatment
- Inability or unwillingness to participate in a trial study
- Rheumatoid Arthritis or other inflammatory disorder diagnoses
- Post-traumatic osteoarthritis
- Patients on Coumadin/Steroids/NSAIDs/Tylenol
- Diabetes Mellitus
- Pregnant or lactating women
- Basal joint arthritis of Eaton stage 3
- Patients seeking other treatment for their basal joint arthritis (splint, corticosteroid injection, surgery)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Subjects in the control group will receive a placebo 3 times per day for 6 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03017118